Month two.
Calloway Formulations had twelve employees, a proper laboratory, and a distribution deal sending product across four states.
Dr. Anand — the Johns Hopkins researcher who had started skeptical and was now the most fervent believer in the building — had completed preliminary clinical observations.
Her words, in the careful measured language of academic understatement:
"Preliminary results are extremely encouraging and warrant immediate formal trial."
In normal human language:
"I have never seen anything like this and I need to understand how it works immediately."
Shen Mingzhu approved the formal trials without hesitation.
Then quietly added three new formulations to the development pipeline.
More complex. More precise. Each one a step closer to the full versions he carried in his memory from another world entirely.
He was not in a hurry.
He had ten thousand years of patience.
He would rebuild this world's medicine the same way he had built immortal cultivation pills.
One careful step at a time.
Ryan's old friends were losing their minds.
The same group of pleasant, directionless men who had watched Ryan Calloway sleep through his own life for years were now calling Derek in various states of confused distress.
Ryan wasn't coming to poker night.
Ryan had turned down a free trip to Miami.
Ryan had been seen at 6 AM at a laboratory supply store, carrying precision equipment himself because it needed careful handling.
"He quoted a scientific paper at me," one of them told Derek, voice hushed like he was reporting a supernatural event. "About amino acid bioavailability. Ryan. Quoted. A scientific paper."
"He's going through something," Derek said sagely.
This was the most accurate thing Derek had ever said.
The article that changed everything ran on a Thursday.
Not a scientific journal. Not a business publication.
A lifestyle magazine. Mid-size. The kind that ran pieces about morning routines and apartment renovations and occasionally stumbled onto something real.
The journalist had interviewed six of Derek's original twenty clients. She had spoken to Dr. Anand, who had been carefully non-committal in the way of researchers who don't want to oversell preliminary data but couldn't keep the excitement entirely out of her voice.
The headline:
THE PILL THAT SHOULDN'T WORK — AND WHY IT DOES
Inside the mysterious formulations of Ryan Calloway — the man nobody saw coming.
It went viral by Friday morning.
Not supplement-industry viral.
Actually viral.
The kind where people who had never thought about supplements in their lives were sharing it because the story was too strange and too compelling to ignore. A nobody with no backing, no credentials, no history in the industry, producing formulations that were making researchers at major institutions sit up and pay attention.
The comments were equal parts fascination and suspicion.
"This sounds fake."
"My sister tried ReVita two weeks ago. It's not fake."
"Who IS this guy?"
Good question.
The answer, as far as the public was concerned, was: nobody.
Ryan Calloway had no LinkedIn. No professional history. No published research. No academic credentials in any relevant field.
What he had was results that couldn't be argued with and a face that photographed extremely well, which the internet noted with predictable enthusiasm.
His phone stopped ringing and started screaming.
Podcast requests. Interview requests. Investment inquiries. A message from a television producer who wanted to do a documentary. Two messages from people claiming to be lawyers representing companies who wanted to discuss licensing.
He responded to the investment inquiries first.
Filtered them by seriousness. Scheduled meetings. Attended each one with the calm of a man who had once negotiated the terms of an entire cultivation world's survival and found corporate boardrooms comparatively relaxing.
He turned down the documentary.
He accepted three investment meetings and came out of all three with offers.
He accepted one — a mid-size health investment firm with a clean portfolio and a managing partner named James Okafor who was the first person in any of these meetings to ask genuinely intelligent questions about the underlying science rather than just the revenue projections.
Shen Mingzhu respected that.
He also respected that James hadn't tried to lowball him.
The deal valued Calloway Formulations at twenty-two million dollars.
Derek found out at dinner.
He put his chopsticks down very slowly.
"Twenty-two million," he said.
"Correct."
"Six weeks ago you had two hundred and forty dollars."
"Correct."
"Ryan." Derek looked at him with the expression of a man experiencing a genuine philosophical crisis. "What are you?"
Shen Mingzhu served him more hotpot.
"Hungry," he said. "Eat."
Elena heard the valuation figure from her CFO before she heard it from him.
She came home that evening and looked at him across the kitchen with an expression he had learned to read — the one that meant she was recalibrating something internal.
"Twenty-two million," she said.
"The distribution partnership increases the valuation considerably," he said. "You should renegotiate your equity terms. I'll accept the revised offer."
She stared at him. "You're offering to give me a better deal than we agreed."
"You gave me the foundation to scale. It's fair."
"Ryan—"
"It's fair," he said again. Quietly. Final.
She was silent for a moment.
"You know," she said carefully, "most people in your position would be trying to squeeze every advantage they could get."
"I'm aware."
"So why aren't you?"
He looked at her.
"Because I don't need to," he said simply. "And because you don't deserve to be taken advantage of. Not again."
The last two words landed softly.
But they landed.
Elena looked away first.
Something in her expression shifted — small, subtle, the way ice shifts in late winter when the temperature changes by a single degree and nothing looks different yet but everything underneath has started to move.
She didn't say anything else.
But that night at dinner she sat closer than usual.
And she stayed at the table long after the food was gone.
The trouble arrived the following week.
His name was Garrett.
Freelance journalist. Midsize online publication. The particular kind of reporter who experienced other people's success as a personal insult and called it investigative journalism.
The article he published was creative, Shen Mingzhu would give him that.
It suggested Ryan Calloway was either concealing something criminal, being used by Elena to generate positive press during her company's recovery, or running sophisticated supplement fraud dressed up as innovation.
It also attacked the clinical observations. Suggested the results were being misrepresented. Called Dr. Anand's preliminary findings "anecdotal at best and manipulated at worst."
Dr. Anand's response arrived forty-eight hours later.
It was twelve pages long.
It was the most thorough, methodical, and quietly devastating academic takedown Shen Mingzhu had ever read in this world's language.
It ended with a single sentence that spread across scientific social media like wildfire:
"I would invite Mr. Garrett to visit our facility, review our methodology, and then explain to our sixty-three trial participants — in person — why their documented improvements are not real."
The article was retracted within a week.
Garrett deleted his account shortly after.
But the attack had revealed something important.
Someone had fed Garrett the story. Someone with enough inside knowledge of Calloway Formulations' early financials to make the fraud angle sound plausible.
Someone who had been watching. Waiting. Looking for a crack.
Shen Mingzhu sat with this information the same way he had once sat with intelligence about enemy sect movements.
Quietly. Patiently. Mapping the edges of a threat before it fully revealed itself.
Carter.
Ryan's older brother had gone quiet after their confrontation. Too quiet. The investment inquiry through Priya had been — he now suspected — information gathering dressed as business interest.
He filed this away.
He didn't move yet.
In cultivation, the worst thing you could do was strike before you understood the full formation.
He would wait.
He would watch.
And when Carter moved again —
He would be ready.
That evening Elena found him at the kitchen table, notepad open, writing formulation notes for the next development phase.
She set a cup of tea next to him without a word.
He looked up.
She was already walking away.
"Elena."
She stopped. Didn't turn around.
"Thank you," he said.
A pause.
"You've been working since five this morning," she said to the wall. "You need to sleep."
"Noted."
She walked away.
But he noticed she left the hallway light on.
She always turned it off before bed.
Tonight she left it on.
For him.
He looked at the cup of tea.
Still steaming. Made exactly the way he drank it — he had never told her how he took it. She had simply noticed.
He picked it up.
Took a slow sip.
Outside, the city hummed and glittered through the apartment windows, indifferent and enormous and nothing like any world he had known before.
And Shen Mingzhu — ten thousand years old, former Grand Elder, Pill God, a man who had nearly touched immortality —
Sat in a warm kitchen with a cup of tea made by someone who had quietly been paying attention.
And felt, in some undeniable and inconvenient way—
At home.
He had fallen through a crack in the universe.
He had landed in the wrong world.
He had stayed for all the right reasons.
But somewhere between the formulations and the dinners and the hallway at 2 AM—
The reasons had changed.
And he hadn't even noticed.